XML 49 R31.htm IDEA: XBRL DOCUMENT v3.20.1
Derivative Instruments (Tables)
3 Months Ended
Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments Reported in Financial Position The detail of derivative instruments is shown below (in thousands, except number of instruments):
Derivatives Not Designated
as Hedging Instruments
Location in the Condensed Consolidated Statements of Financial PositionMarch 31, 2020December 31, 2019
Number of
Instruments
Notional
Amounts
Estimated
Fair Value
Number of
Instruments
Notional
Amounts
Estimated
Fair Value
Equity-indexed optionsOther invested assets466  $2,669,500  $125,988  473  $2,654,600  $256,005  
Equity-indexed embedded derivativePolicyholders’ account balances103,593  2,545,271  630,952  101,950  2,527,205  731,552  
Schedule of Derivative Instruments Reported in Statements of Operations
Derivatives Not Designated
as Hedging Instruments
Location in the Condensed Consolidated Statements of OperationsGains (Losses) Recognized in Income on Derivatives
Three months ended March 31,
20202019
Equity-indexed optionsNet investment income$(108,095) $66,485  
Equity-indexed embedded derivativeInterest credited to policyholders’ account balances89,581  (58,156) 
Schedule of Information Regarding Company's Exposure to Credit Loss on the Options Holds
Information regarding the Company’s exposure to credit loss on the options it holds is presented below (in thousands):
  March 31, 2020
CounterpartyMoody/S&P
Rating
Options Fair
Value
Collateral  Held in CashCollateral Held in Invested AssetsTotal
Collateral Held
Collateral Amounts used to Offset ExposureExcess CollateralExposure
Net of
Collateral
BarclaysBaa2/BBB$26,494  $(87) $28,000  $27,913  $26,494  $1,419  $—  
Credit SuisseBaa2/BBB+1,459  1,590  —  1,590  1,459  131  —  
Goldman-SachsA3/BBB+709  640  —  640  640  —  69  
INGBaa1/A-23,193  7,560  16,000  23,560  23,193  367  —  
Morgan StanleyA3/BBB+10,421  3,136  9,000  12,136  10,421  1,715  —  
NATIXIS*A1/A+19,961  21,250  —  21,250  19,961  1,289  —  
SunTrustA3/A-25,018  10,040  17,000  27,040  25,018  2,022  —  
Wells FargoA2/A-18,733  5,350  15,000  20,350  18,733  1,617  —  
       Total$125,988  $49,479  $85,000  $134,479  $125,919  $8,560  $69  

  December 31, 2019
CounterpartyMoody/S&P
Rating
Options Fair
Value
Collateral  Held in CashCollateral Held in Invested AssetsTotal
Collateral Held
Collateral Amounts used to Offset ExposureExcess CollateralExposure
Net of
Collateral
BarclaysBaa3/BBB$54,583  $27,343  $28,000  $55,343  $54,583  $760  $—  
Credit SuisseBaa2/BBB+7,117  7,390  —  7,390  7,009  381  108  
Goldman-SachsA3/BBB+1,053  930  —  930  930  —  123  
INGBaa1/A-30,330  14,940  16,000  30,940  30,330  610  —  
Morgan StanleyA3/BBB+34,988  25,926  9,000  34,926  34,926  —  62  
NATIXIS*A1/A+29,918  30,200  —  30,200  29,918  282  —  
SunTrustA3/A-60,360  41,720  17,000  58,720  58,645  75  1,715  
Wells FargoA2/A-37,656  24,110  15,000  39,110  37,656  1,454  —  
       Total$256,005  $172,559  $85,000  $257,559  $253,997  $3,562  $2,008  

*Collateral is prohibited from being held in invested assets